<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Canadian Pharmacy</title>
    <link>http://www.canadarxpharmacy.com</link>
    <description>Weekly Updates in the pharmacy world in Canada.  Upcoming Events, News and Articles. </description>
    <generator>Feeder 1.2.4.1 http://reinventedsoftware.com/feeder/</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <language>en-us</language>
    <pubDate>Mon, 10 Apr 2006 13:33:57 -0700</pubDate>
    <lastBuildDate>Mon, 10 Apr 2006 13:33:57 -0700</lastBuildDate>
    <item>
      <title>Drug prices for US elderly up 6 pct in 2005: study</title>
      <link>http://news.yahoo.com/s/nm/20060410/hl_nm/drugs_prices_dc&amp;printer=1;_ylt=AkyMYPsfx4pz8JsoKFwct.cR.3QA;_ylu=X3oDMTA3MXN1bHE0BHNlYwN0bWE</link>
      <description><![CDATA[U.S. prices for brand name prescription medications used most by older patients rose an average 6 percent in 2005, outpacing inflation for the sixth year in a row, according to a report released on Monday.<br><br>

In fact, the price drug makers charge wholesalers and other purchases for branded drugs has risen 40 percent since 1999, compared with inflation, which grew 17 percent, AARP researchers found. In 2005, inflation was 3.4 percent.]]></description>
      <pubDate>Mon, 10 Apr 2006 13:33:56 -0700</pubDate>
      <guid isPermaLink="false">drug-prices-for-us-elderly-up-6-pct-in-2005-study</guid>
    </item>
    <item>
      <title>Innovative Technology For Production Of New Pharmaceuticals Forms Basis Of New Company</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=40148</link>
      <description><![CDATA[Ghent, Belgium and Espoo, Finland - Plants produce a lot of valuable pharmaceuticals - but rather slowly and in small quantities. So, scientists from the Flanders Interuniversity Institute for Biotechnology (VIB) have together with Ghent University and VTT Technical Research Centre of Finland developed a technology to increase the production of pharmaceuticals in plant cells. The technology forms the foundation for the new company SoluCel. This week, the authoritative scientific journal PNAS is publishing results from th]]></description>
      <pubDate>Tue, 28 Mar 2006 08:30:36 -0800</pubDate>
      <guid isPermaLink="false">innovative-technology-for-production-of-new-pharmaceuticals-forms-basis-of-new-company</guid>
    </item>
    <item>
      <title>Schering AG Supervisory Board Supports Bayer Offer</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=40405</link>
      <description><![CDATA[The Supervisory Board of Schering AG, Germany (FSE: SCH, NYSE: SHR) today announced that it shares the positive view of the Executive Board of Schering AG regarding the takeover offer by Bayer AG. The Supervisory Board will also recommend to Schering AG's shareholders to accept the offer once the formal offer documents have been published and assessed. 
]]></description>
      <pubDate>Tue, 28 Mar 2006 08:26:09 -0800</pubDate>
      <guid isPermaLink="false">schering-ag-supervisory-board-supports-bayer-offer</guid>
    </item>
    <item>
      <title>GSK To Tag Antiretroviral Drug Trizivir Bottles Shipped To U.S. With Tracking Device In Pilot Project To Prevent Counterfeiting</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=40354</link>
      <description><![CDATA[GlaxoSmithKline on Wednesday announced it will begin attaching a radio frequency identification device to bottles of its triple-combination antiretroviral drug Trizivir shipped to the U.S. as part of a pilot project that aims to fight counterfeiting of the drug, Reuters reports.]]></description>
      <pubDate>Tue, 28 Mar 2006 08:25:24 -0800</pubDate>
      <guid isPermaLink="false">gsk-to-tag-antiretroviral-drug-trizivir-bottles-shipped-to-us-with-tracking-device-in-pilot-project-to-prevent-counterfeiting</guid>
    </item>
    <item>
      <title>Potential Flu Pandemic - HHS Buys More Antiviral, USA</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=40173</link>
      <description><![CDATA[HHS Secretary Mike Leavitt today announced additional purchases of antiviral drugs that could be used in the event of a potential influenza pandemic. The department has ordered 2.2 million more treatment courses of antiviral drug zanamivir (Relenza®) from GlaxoSmithKline and 3.8 million more treatment courses of oseltamivir phosphate (Tamiflu®) from Roche. With these purchases, the Strategic National Stockpile will have a total of 26 million treatment courses of antiviral drugs for distribution to the states when an influenza pandemic is deemed to be imminent. ]]></description>
      <pubDate>Tue, 28 Mar 2006 08:22:37 -0800</pubDate>
      <guid isPermaLink="false">potential-flu-pandemic-hhs-buys-more-antiviral-usa</guid>
    </item>
    <item>
      <title>Acrux Patent Portfolio Advances In USA</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=38727</link>
      <description><![CDATA[New patent granted in USA for MDTSÂ® drug delivery system
Protection against copies of Acrux unique transdermal sprays extended out to 2022
Nine patents now granted in USA ]]></description>
      <pubDate>Wed, 08 Mar 2006 09:52:21 -0800</pubDate>
      <guid isPermaLink="false">acrux-patent-portfolio-advances-in-usa</guid>
    </item>
    <item>
      <title>Data In Drug Promotional Brochures Can Be Inaccurate</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=38819</link>
      <description><![CDATA[Brochures produced by pharmaceutical companies to promote drugs to doctors don't always present accurate data. A study published today in the open access journal BMC Family Practice found that three out of twenty promotional brochures studied contained data that was different from the original study on the effects of the drug. Although the differences were small, the authors of the study recommend that doctors review original studies before changing their drug prescribing behaviour based on promotional brochures. ]]></description>
      <pubDate>Wed, 08 Mar 2006 09:51:48 -0800</pubDate>
      <guid isPermaLink="false">data-in-drug-promotional-brochures-can-be-inaccurate</guid>
    </item>
    <item>
      <title>US District Court Dismisses Abbott Laboratories&apos; Litigation Against Takeda Pharmaceutical</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=38850</link>
      <description><![CDATA[Tokyo, (JCN) - Takeda Pharmaceutical announced on March 2 that the US District Court in Chicago dismissed a legal action launched by Abbott Laboratories against Takeda Pharmaceutical in 2005. ]]></description>
      <pubDate>Wed, 08 Mar 2006 09:51:16 -0800</pubDate>
      <guid isPermaLink="false">us-district-court-dismisses-abbott-laboratories-litigation-against-takeda-pharmaceutical</guid>
    </item>
    <item>
      <title>Many Post-Market Studies Of New Medications Not Completed, FDA Report States</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=38919</link>
      <description><![CDATA[Many post-market studies that pharmaceutical companies have promised to conduct on medications approved by FDA remain uncompleted, according to an annual report released by the agency on Thursday, the Wall Street Journal reports.]]></description>
      <pubDate>Wed, 08 Mar 2006 09:50:36 -0800</pubDate>
      <guid isPermaLink="false">many-postmarket-studies-of-new-medications-not-completed-fda-report-states</guid>
    </item>
    <item>
      <title>Nevada Pharmacy Board Approves Prescription Drug Reimportation Regulations</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=38920</link>
      <description><![CDATA[The Nevada State Board of Pharmacy on Wednesday voted 4-3 to approve regulations that would allow state residents to purchase lower-cost prescription drugs from Canadian pharmacies, the Las Vegas Review-Journal reports. In April, the board will hold a formal public hearing on the regulations, and, provided that the board approves them a second time, they will move to the Legislative Commission for consideration (Vogel, Las Vegas Review-Journal, 3/2).]]></description>
      <pubDate>Wed, 08 Mar 2006 09:50:07 -0800</pubDate>
      <guid isPermaLink="false">nevada-pharmacy-board-approves-prescription-drug-reimportation-regulations</guid>
    </item>
    <item>
      <title>Frost &amp; Sullivan To Host 2006 Excellence In Healthcare Awards Banquet</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=38780</link>
      <description><![CDATA[Main Category: Pharma Industry News
Article Date: 03 Mar 2006 - 19:00pm (UK)<br><br>

Frost & Sullivan will host its prestigious 2006 Excellence in Healthcare Awards Banquet on Monday 13th March, 2006 at the Hilton London Heathrow Airport Hotel. <br><br>

At the banquet, Frost & Sullivan will honour companies for their business achievements in a variety of regional and global healthcare markets. The companies commended as Award winners are those with the diligence, perseverance as well as dedication required to develop a successful business plan and excel in the increasingly competitive global marketplace.]]></description>
      <pubDate>Wed, 08 Mar 2006 09:36:27 -0800</pubDate>
      <guid isPermaLink="false">frost-sullivan-to-host-2006-excellence-in-healthcare-awards-banquet</guid>
    </item>
    <item>
      <title>Share Of Pharmaceutical Spending In Total Healthcare Expenditure Remains High Across Most EU Countries</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=37057</link>
      <description><![CDATA[Most EU member states have publicly funded healthcare systems and the proportion of pharmaceutical expenditure, as a portion of GDP remains high, particularly in countries such as Italy, Portugal, France, Spain and Greece. Also, a vast majority of the EU countries with the exception of Belgium, Ireland and Luxembourg are witnessing a rise in the share of pharmaceutical spending in the total healthcare expenditure thus prompting governments to adopt urgent cost containment measures through more stringent norms in their pharmaceutical policies. ]]></description>
      <pubDate>Mon, 06 Feb 2006 09:17:26 -0800</pubDate>
      <guid isPermaLink="false">share-of-pharmaceutical-spending-in-total-healthcare-expenditure-remains-high-across-most-eu-countries</guid>
    </item>
    <item>
      <title>New FDA Policy To Declare Federal Medication Labels Supersede State Product Liability Laws</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=36262</link>
      <description><![CDATA[FDA plans to issue a new policy that would declare that federally approved labels on prescription drugs supersede state laws on product liability as part of a long-delayed rule on medication labels, according to individuals familiar with the situation, the Wall Street Journal reports.]]></description>
      <pubDate>Thu, 02 Feb 2006 09:47:01 -0800</pubDate>
      <guid isPermaLink="false">new-fda-policy-to-declare-federal-medication-labels-supersede-state-product-liability-laws</guid>
    </item>
    <item>
      <title>The drugs they need</title>
      <link>http://www.latimes.com/news/printedition/opinion/la-ed-drugs11jan11,1,1984780.story?ctrack=1&amp;cset=true</link>
      <description><![CDATA[NO ONE REALLY EXPECTED the new Medicare prescription drug program to be "fail safe" (although federal officials actually used that phrase). But early signs, in California and other states, are that the days-old program may be failing those who need it most.]]></description>
      <pubDate>Thu, 02 Feb 2006 09:46:28 -0800</pubDate>
      <guid isPermaLink="false">the-drugs-they-need</guid>
    </item>
    <item>
      <title>Editorials, Opinion Pieces Address Problems With Medicare Prescription Drug Benefit</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=36326</link>
      <description><![CDATA[Several newspapers recently published editorials and opinion pieces that addressed problems with the new Medicare prescription drug benefit. Summaries appear below.]]></description>
      <pubDate>Thu, 02 Feb 2006 09:44:39 -0800</pubDate>
      <guid isPermaLink="false">editorials-opinion-pieces-address-problems-with-medicare-prescription-drug-benefit</guid>
    </item>
    <item>
      <title>&apos;Bird Flu&apos; Infections In Humans Prompt New Investigation At Saint Louis University</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=36353</link>
      <description><![CDATA[In 1918, nearly 40 million people died in a flu pandemic. Three such pandemics have occurred during the last 100 years. 

When a new strain of flu infects people, the infection can spread around the world quickly. This is what could potentially happen with some new human flu viruses that come from bird flu viruses. 
]]></description>
      <pubDate>Thu, 02 Feb 2006 09:43:51 -0800</pubDate>
      <guid isPermaLink="false">bird-flu-infections-in-humans-prompt-new-investigation-at-saint-louis-university</guid>
    </item>
    <item>
      <title>BiovaxID™ Yields 89 Percent Survival In Patients With Aggressive Non-Hodgkins</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=36661</link>
      <description><![CDATA[Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI) and its subsidiary, Biovest International, Inc. (OTCBB:BVTI), report follow-up data to a Phase 2 trial conducted by the National Cancer Institute (NCI) that shows Biovest's BiovaxID yielded an 89% survival rate in mantle cell lymphoma patients. The median follow-up was 3.8 years.]]></description>
      <pubDate>Thu, 02 Feb 2006 09:42:45 -0800</pubDate>
      <guid isPermaLink="false">biovaxid™-yields-89-percent-survival-in-patients-with-aggressive-nonhodgkins</guid>
    </item>
    <item>
      <title>New Web Site For The Generic Pharmaceutical Association (GPhA)</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=35883</link>
      <description><![CDATA[The Generic Pharmaceutical Association (GPhA) is pleased to announce the launch of its new Web site.: 
www.gphaonline.org ]]></description>
      <pubDate>Mon, 16 Jan 2006 13:33:35 -0800</pubDate>
      <guid isPermaLink="false">new-web-site-for-the-generic-pharmaceutical-association-gpha</guid>
    </item>
    <item>
      <title>FDA To Announce New Guidelines For Prescription Drug Research</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=36080</link>
      <description><![CDATA[FDA as early as Thursday is expected to announce new guidelines for the early stages of drug development, including eased restrictions on the production of small batches of experimental drugs and modified regulations for the number of animal studies required before certain drugs are tested in humans, the Wall Street Journal reports. The guidelines are intended to improve the new drug pipeline and help pharmaceutical companies and academic researchers "get better information about [new products] at the beginning of the development process," according to the Journal.]]></description>
      <pubDate>Mon, 16 Jan 2006 13:31:24 -0800</pubDate>
      <guid isPermaLink="false">fda-to-announce-new-guidelines-for-prescription-drug-research</guid>
    </item>
    <item>
      <title>Canadameds stays involved to bring more affordable prescription drugs to their patients.</title>
      <link>http://www.canadameds.com/canada_pharmacy_political_lobby.html</link>
      <description><![CDATA[How we are staying Involved
We at Canadameds.com believe in fighting for our patients' right to access safe, affordable, prescription drugs. As a leader in the online-pharmacy industry we feel it is important to make a difference, and we do. ]]></description>
      <pubDate>Mon, 16 Jan 2006 13:29:59 -0800</pubDate>
      <guid isPermaLink="false">canadameds-stays-involved-to-bring-more-affordable-prescription-drugs-to-their-patients</guid>
    </item>
    <item>
      <title>Acquisition Of KuDOS Pharmaceuticals Will Enhance AstraZeneca&apos;s Ability To Generate Novel Cancer Treatments</title>
      <link>http://www.medicalnewstoday.com/medicalnews.php?newsid=35420</link>
      <description><![CDATA[AstraZeneca announced an agreement to acquire KuDOS Pharmaceuticals Limited, a privately-owned UK biotechnology company, focused on the discovery and development of oncology therapies based on the inhibition of DNA repair. The total share capital of the company will be purchased for $210m cash, subject to debt and working capital adjustment. The transaction is expected to close early in 2006.]]></description>
      <pubDate>Thu, 05 Jan 2006 12:46:06 -0800</pubDate>
      <guid isPermaLink="false">acquisition-of-kudos-pharmaceuticals-will-enhance-astrazenecas-ability-to-generate-novel-cancer-treatments</guid>
    </item>
    <item>
      <title>Cross Border RX</title>
      <link>http://www.cbc.ca/news/background/drugs/%00</link>
      <description><![CDATA[The cross-border trade in prescription drugs is booming and Canadian pharmacies are reaping the benefits. Low Canadian drug prices, a low Canadian dollar and close proximity add up to big savings for American consumers hungry for affordable medication.]]></description>
      <pubDate>Thu, 05 Jan 2006 12:45:10 -0800</pubDate>
      <guid isPermaLink="false">cross-border-rx</guid>
    </item>
    <item>
      <title>Manitoba Internet Pharmacies</title>
      <link>http://www.brandonsun.com/story.php?story_id=13478%00</link>
      <description><![CDATA[Origins: Started in late 1999 when a young Manitoba pharmacy graduate began selling Nicorette gum, a stop-smoking aid, over Ebay at the same time another Manitoba pharmacist started selling small quantities of insulin supplies to North Dakota.]]></description>
      <pubDate>Thu, 05 Jan 2006 12:44:45 -0800</pubDate>
      <guid isPermaLink="false">manitoba-internet-pharmacies</guid>
    </item>
    <item>
      <title>Health Canada warns consumers to return bottles of Euro-ASA 80 mg chewable tablets to place of purchase</title>
      <link>http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/2005/2005_133_e.html%00</link>
      <description><![CDATA[OTTAWA - Health Canada is warning consumers that two lots of Euro-ASA 80 mg orange flavoured, chewable tablets (Euro-ASA Chewable Tablet) lack child-resistant packaging, even though the label indicates the bottles are child resistant.]]></description>
      <pubDate>Thu, 05 Jan 2006 12:43:41 -0800</pubDate>
      <guid isPermaLink="false">health-canada-warns-consumers-to-return-bottles-of-euroasa-80-mg-chewable-tablets-to-place-of-purchase</guid>
    </item>
    <item>
      <title>The lure of Canadian drugs may disappear</title>
      <link>http://www.startribune.com/stories/789/5761046.html%00</link>
      <description><![CDATA[Canadian pharmacists are likely to lose a big chunk of their $1 billion-a-year mail-order business when Americans on Medicare start getting taxpayer help paying for drugs starting next month.]]></description>
      <pubDate>Thu, 05 Jan 2006 12:43:18 -0800</pubDate>
      <guid isPermaLink="false">the-lure-of-canadian-drugs-may-disappear</guid>
    </item>
    <item>
      <title>Multiple forms of drugs causing errors</title>
      <link>http://www.montereyherald.com/mld/montereyherald/living/health/13291267.htm%00</link>
      <description><![CDATA[PHILADELPHIA - Dr. James Kmetzo knows that Diltiazem is usually the drug of choice for high blood pressure.<br><br> But then his choices explode. Cardizem, Dilacor and Tiazac are all brand names for Diltiazem. But should he prescribe Cardizem CD, Cardizem SR, Cardizem LA, Dilacor XR or Tiazac? All four come in varying doses, some taken once a day, some twice, some crushable, others not.]]></description>
      <pubDate>Thu, 05 Jan 2006 12:41:36 -0800</pubDate>
      <guid isPermaLink="false">multiple-forms-of-drugs-causing-errors</guid>
    </item>
  </channel>
</rss>